Speece Thorson Capital Group Inc buys $15,886,901 stake in Varian Medical Systems (VAR)

Varian Medical Systems (VAR) : Speece Thorson Capital Group Inc scooped up 2,415 additional shares in Varian Medical Systems during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 26, 2016. The investment management firm now holds a total of 179,513 shares of Varian Medical Systems which is valued at $15,886,901.Varian Medical Systems makes up approximately 3.41% of Speece Thorson Capital Group Inc’s portfolio.

Other Hedge Funds, Including , Pggm Investments reduced its stake in VAR by selling 275,921 shares or 58.06% in the most recent quarter. The Hedge Fund company now holds 199,285 shares of VAR which is valued at $17,636,723. Varian Medical Systems makes up approx 0.09% of Pggm Investments’s portfolio.Gemmer Asset Management reduced its stake in VAR by selling 300 shares or 77.72% in the most recent quarter. The Hedge Fund company now holds 86 shares of VAR which is valued at $7,485.Boys Arnold Co Inc boosted its stake in VAR in the latest quarter, The investment management firm added 485 additional shares and now holds a total of 5,710 shares of Varian Medical Systems which is valued at $493,801. Varian Medical Systems makes up approx 0.08% of Boys Arnold Co Inc’s portfolio.Cutler Group Lp reduced its stake in VAR by selling 1,522 shares or 91.69% in the most recent quarter. The Hedge Fund company now holds 138 shares of VAR which is valued at $11,922.

Varian Medical Systems opened for trading at $94.09 and hit $95.06 on the upside on Friday, eventually ending the session at $94.74, with a gain of 0.76% or 0.71 points. The heightened volatility saw the trading volume jump to 11,80,328 shares. Company has a market cap of $9,021 M.

On the company’s financial health, Varian Medical Systems reported $1.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $789.40 million for the quarter, compared to analysts expectations of $782.00 million. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS.

Many Wall Street Analysts have commented on Varian Medical Systems. Company shares were Reiterated by Barrington Research on Jul 28, 2016 to “Outperform”, Firm has raised the Price Target to $ 102 from a previous price target of $93 .

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Company’s customers include university research and community hospitals private and governmental institutions healthcare agencies doctors’ offices and cancer care clinics.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Varian Medical Systems - Is it time to Sell?

Top Brokerage Firms are advising their investors on Varian Medical Systems. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.